VS

Vikas Sharma

Active Director Director DIN 11281782
DIN 11281782 First appointment Sep 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value •••• Premium profile

About Vikas Sharma

Data last updated:

Vikas Sharma is a Director at Orama Life Sciences Private Limited (since 2025). The company operates in Pharma. Orama Life Sciences Private Limited reported revenue of ₹3.08 Cr (FY 2025).

DIN 11281782
Primary Designation Director
Industry Pharma
First Appointment 05 Sep 2025
Oldest Company Age 7 yrs
Largest company Orama Life Sciences Private Limited · ₹3.08 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Orama Life Sciences Private Limited U24304MP2019PTC048935
Director05 Sep 20252019₹3.08 Cr (FY 2025)Active

Board colleagues of Vikas Sharma

Directorship timeline

Open interactive timeline →
Orama Life Sciences Private Limited
Premium access

Shareholding and investment profile for Vikas Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vikas Sharma

Vikas Sharma currently holds 1 directorship: Orama Life Sciences Private Limited (Director, since 05 Sep 2025, revenue ₹3.08 Cr (FY 2025)).

Vikas Sharma was first appointed on 05 Sep 2025 as Director at Orama Life Sciences Private Limited.

The current boards of Vikas Sharma's companies include Garima Mudgal (Orama Life Sciences Private Limited), Narayan Prasad Sharma (Orama Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available